Recruiting Lung Cancer Studies in Paramus
Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
This is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer (NSCLC). This study includes two substudies (substudy A and substudy B) that wi...
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
The purpose of this randomized study is to determine the safety and efficacy of quaratusugene ozeplasmid (Reqorsa) added to osimertinib in NSCLC patients with activating EGFR mutations who have progre...
About Lung Cancer Clinical Trials in Paramus
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Paramus, NJ. These studies are seeking a combined 1,140 participants. Research is being sponsored by BioNTech SE, Genprex, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Paramus — FAQ
Are there lung cancer clinical trials in Paramus?
Yes, there are 2 lung cancer clinical trials currently recruiting in Paramus, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Paramus?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Paramus research site will contact you about next steps.
Are clinical trials in Paramus free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Paramus studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Paramus are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov